Confused? Buy or Sell in volatile market – Analyst report NASDAQ:RAVN, NASDAQ:MOXC, NASDAQ:VYNT, NASDAQ:NVFY

RAVEN INDUSTRIES (NASDAQ:RAVN) EARNINGS INFORMATION (NASDAQ:RAVN)

Raven Industries last issued its earnings data on May 17th, 2021. The conglomerate reported $0.26 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.12. Raven Industries has generated $1.09 earnings per share over the last year and currently has a price-to-earnings ratio of 71.5. Raven Industries has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, August 25th, 2021 based off prior year’s report dates.

IS RAVEN INDUSTRIES A BUY RIGHT NOW? (NASDAQ:RAVN)

3 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Raven Industries in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Raven Industries stock.
Raven Industries

MOXIAN (NASDAQ:MOXC) EARNINGS INFORMATION (NASDAQ:MOXC)

Moxian last released its quarterly earnings results on February 16th, 2021. The reported ($0.02) earnings per share for the quarter. Moxian has generated $0.00 earnings per share over the last year. Moxian has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Friday, August 13th, 2021 based off prior year’s report dates.

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN MOXIAN? (NASDAQ:MOXC)

Wall Street analysts have given Moxian a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Moxian wasn’t one of them. MarketBeat thinks these five companies may be even better buys.

VYANT BIO EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:VYNT)

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN VYANT BIO? (NASDAQ:VYNT)

Wall Street analysts have given Vyant Bio a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Vyant Bio wasn’t one of them. MarketBeat thinks these five companies may be even better buys.

NOVA LIFESTYLE EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:NVFY)

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN NOVA LIFESTYLE? (NASDAQ:NVFY)

Wall Street analysts have given Nova LifeStyle a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Nova LifeStyle wasn’t one of them. MarketBeat thinks these five companies may be even better buys.